Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fast-Tracked Sexual Health Screening Offered With Morning After Pill

30.11.2005


Young women asking for the morning-after pill at pharmacies will be offered fast-tracked screening for Chlamydia, the UK’s most common sexually transmitted infection, in a University of Manchester study.



It is thought that up to one in ten young people under 25 have Chlamydia, a sexually transmitted infection that often has no symptoms and can lead to infertility, although it is very easily treated with just one dose of four tablets in the majority of cases.

With 18,000 women going to pharmacies for emergency contraception each year*, it is hoped that the study will identify and help a previously unknown and potentially large population at risk of sexually transmitted infections – young women who may not use family planning clinics or go to their GPs for contraception, where they would be offered Chlamydia screening.


The women requesting emergency contraception will be given a discreet plain purple box, containing a bottle for their urine sample, free postage and a confidential questionnaire offering them a variety of ways they can receive their diagnosis within three working days. If they are found to have Chlamydia, they and their partner will then be referred to a genito-urinary clinic of their choice for full sexual health screening and treatment. The whole process from test to treatment should be completed in just two weeks.

The study is in response to a Department of Health drive for Primary Care Trusts to offer Chlamydia screening to under 25s in non genito-urinary clinic settings by April 2006. The University of Manchester study, to be launched on 3 January 2006 and funded by The BUPA Foundation, hopes to screen 2,000 women at pharmacies. Chlamydia screening will be offered to another 1,000 women asking for emergency contraception at family planning clinics and 400 asking for it at the Manchester Brook Advisory Service. Thus important information will be gathered for the planning of screening in the Greater Manchester NHS region and possibly throughout the UK.

Dr Loretta Brabin, of the Division of Human Development and Reproduction at the University’s School of Medicine, founded the study. She explained: “This could identify and thus treat a potentially huge unknown population at risk of untreated Chlamydia.”

She added: “The study will not add to the workload of pharmacies – indeed pharmacists are supposed to advise women asking for emergency contraception about sexually transmitted infection. Now they can give them a direct offer of help.

“The study will gather confidential information on the previous STI treatment of clients attending various contraception outlets for the morning-after pill, and their risk of being infected. It will also find out how many women going to pharmacies take the test kit home and how many post it back – that is, whether this is a good system. A good uptake could facilitate further schemes which are this convenient.”

Research nurse Grace Thomas, who is running the study has worked in a busy sexual health clinic in Manchester, agreed: “This is also a great help for women who may be concerned about sexually transmitted infections. Looking at the number of young women going to pharmacies, there is a huge potential there; people at risk of STIs and not tapping into the more traditional healthcare services available.

“Chlamydia really is so simple to treat, in most cases four tablets there and then and, as long as your partner is treated too, that is the end of it. So I would encourage young women to take the test kit and post it back - it is to their benefit.”

jo Nightingale | alfa
Further information:
http://www.manchester.ac.uk
http://www.manchester.ac.uk/aboutus/news/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>